# Postpartum Hemorrhage Prevention in Patients With Preeclampsia (PHP3 Study)

> **NCT02221830** · EARLY_PHASE1 · COMPLETED · sponsor: **University of Colorado, Denver** · enrollment: 66 (actual)

## Conditions studied

- Preeclampsia

## Interventions

- **DRUG:** Oxytocin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02221830
- **Lead sponsor:** University of Colorado, Denver
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-02
- **Primary completion:** 2019-07-17
- **Final completion:** 2019-07-17
- **Target enrollment:** 66 (ACTUAL)
- **Last updated:** 2021-05-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02221830

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02221830, "Postpartum Hemorrhage Prevention in Patients With Preeclampsia (PHP3 Study)". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT02221830. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*